Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas-Reference-Cited by-同舟云学术

Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas

Published:2021-01 Issue:1 Volume:54 Page:116-131.e10
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Dersh Devin,Phelan James D.,Gumina Megan E.,Wang Boya,Arbuckle Jesse H.,Holly Jaroslav,Kishton Rigel J.,Markowitz Tovah E.,Seedhom Mina O.,Fridlyand Nathan,Wright George W.,Huang Da Wei,Ceribelli Michele,Thomas Craig J.,Lack Justin B.,Restifo Nicholas P.,Kristie Thomas M.,Staudt Louis M.,Yewdell Jonathan W.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference88 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

2. MHC-II neoantigens shape tumour immunity and response to immunotherapy;Alspach;Nature,2019

3. Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study;Ansell;J. Clin. Oncol.,2019

4. xCell: digitally portraying the tissue cellular heterogeneity landscape;Aran;Genome Biol.,2017

5. Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase;Berg;J. Pharmacol. Exp. Ther.,2001

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SUGT1 regulates the progression of ovarian cancer through the AKT/PI3K/mTOR signaling pathway;Translational Oncology;2024-11

2. Pharmacological induction of MHC-I expression in tumor cells revitalizes T cell antitumor immunity;JCI Insight;2024-08-06

3. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation;eLife;2024-07-08

4. IFNγ mediates the resistance of tumor cells to distinct NK cell subsets;Journal for ImmunoTherapy of Cancer;2024-07

5. Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma;Blood Advances;2024-06-26